Tele-dermatology for Skin Cancer Management

Abstract

Teledermatology plays a significant role in the UK National Health Service (NHS) for the management of skin cancers by enhancing early detection, diagnosis, and treatment pathways. It uses digital platforms to allow dermatologists to remotely evaluate skin lesions, including potential malignancies, based on high-quality images and patient information submitted by general practitioners (GPs) or other healthcare providers.This approach has proven particularly valuable in reducing wait times for specialist consultations, which is critical for skin cancers where early detection greatly improves outcomes. Through teledermatology, GPs can rapidly refer suspicious lesions to dermatologists, who assess whether further investigation, such as a biopsy or urgent in-person consultation, is required. It helps prioritize high-risk patients for fast-track appointments under the NHS's two-week referral rule for suspected cancers. Teledermatology also facilitates efficient triaging of cases, enabling healthcare systems to manage resources more effectively. Low-risk cases can often be monitored remotely or managed within primary care, reducing unnecessary hospital visits, and easing the burden on specialist services. During the COVID-19 pandemic, the adoption of teledermatology surged, helping maintain continuity of care for skin cancer patients despite restrictions on in-person visits. Overall, teledermatology in the NHS enhances access to specialist care, speeds up the diagnostic process, and improves the management of skin cancers, making it a crucial tool in modern dermatological practice. This article describes a tele-dermatology service and its outcomes.